Hanne Leth Hillman joins Zealand Pharma
pharmafile | January 13, 2011 | Appointment | Medical Communications | Hanne Leth Hillman, Zealand Pharma, appointment, medical communications
Danish biopharmaceutical company Zealand Pharma has appointed Hanne Leth Hillman as VP of investor relations and corporate communications.
She will join Zealand Pharma from NeuroSearch, where she was director of investor relations (IR) and capital market relations, and has more than 15 years of experience in equity markets and the life science industry.
“Hanne’s deep understanding of the investor community and comprehensive biotech expertise brings all the competencies we need to communicate clearly and effectively with our shareholders, potential investors and other key external stakeholders,” said David Solomon, president and chief executive of Zealand Pharma.
“Following the recent IPO of Zealand Pharma, we look forward to building our IR programme, and Hanne will play a leading role in the further development of our investor and media relations.”
Hanne will begin her work in Zealand Pharma on 1 March 2011 and will report to David Solomon.
Related Content
Zealand’s Zegalogue treatment for hypoglycemia approved by FDA
The FDA have approved Zealand Pharma’s Zegalogue therapy for the treatment of severe hypoglycemia in …
Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …
Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …